Emilia Entcheva, Ph.D.

AIMBE College of Fellows Class of 2016
For pioneering work in cardiac optogenetics–spearheading the development and biophysical characterization of new bioengineering tools towards all-optical electrophysiology

Engineering biology through DNA’s environment – NSF awards $16 million to understand and control epigenetic effects

Via National Science Foundation | September 12, 2018

To advance the engineering of biology at the molecular and cellular levels, the National Science Foundation (NSF) has awarded $16 million for research to characterize the regulation of gene activity and expression, and to create strategies to modify those processes without altering the DNA sequence.

Chromatin — a combination of DNA, RNA and proteins within a cell’s nucleus — can be modified by attaching additional molecules. This can cause altered gene expression without actually changing the cell’s DNA. These so-called epigenetic changes can alter an organism’s traits, or phenotype, and may even be passed to offspring.


The NSF EFRI Chromatin and Epigenetic Engineering (CEE) investment will support potentially transformative research by eight interdisciplinary teams:

  • Ascribing function to chromatin with coordinated live-cell epigenomic sensors and scalpels, Albert Keung, North Carolina State University, with Caroline Laplante and Balaji Rao
  • Engineering technologies to determine causal relationships between chromatin structure and gene regulation, Charles Gersbach, Duke University, with Brenton Hoffman, Michael Rubinstein and Xiling Shen
  • Epigenetic cell reprogramming in situ: A novel tool for regenerative engineering, Guillermo Ameer, Northwestern University, with Panagiotis Ntziachristos and Hariharan Subramanian
  • Epigenomic regulation over multiple length scales: Understanding chromatin modifications through label free imaging and multi-scale modeling, Juan De Pablo, University of Chicago, with Ali Shilatifard and Hao Zhang
  • Human cardiac opto-epigenetics with HDAC inhibitors, Emilia Entcheva, George Washington University, with Shu Jia, Zhenyu Li, Ralph Mazitschek and Alejandro Villagra
  • Macrogenomic engineering via modulation of chromatin nanoenvironment, Vadim Backman, Northwestern University, with Michael Kennedy, Hemant Roy and Igal Szleifer
  • Optically controlled localized epigenetic chromatin remodeling with photoactivatable CRISPR-dCas9, Lev Perelman, Beth Israel Deaconess Medical Center, with Irving Itzkan, J. Thomas Lamont, Le Qiu and Darren Roblyer
  • Sculpting the genome by design: Epigenetic and chromatin looping inputs to measure and manipulate chromatin organization and dynamics, Megan King, Yale University, with Simon G. Mochrie and Corey O’Hern

Continue reading

Emilia Entcheva, Ph.D. To be Inducted into Medical and Biological Engineering Elite

Via AIMBE | January 20, 2016

WASHINGTON, D.C.— The American Institute for Medical and Biological Engineering (AIMBE) has announced the pending induction of Emilia Entcheva, Ph.D., Professor of Biomedical Engineering, Biomedical Engineering, George Washington University, to its College of Fellows. Dr. Entcheva was nominated, reviewed, and elected by peers and members of the College of Fellows For pioneering work in cardiac optogenetics–spearheading the development and biophysical characterization of new bioengineering tools towards all-optical electrophysiology.